Abstract

PurposeNodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients.MethodsWe studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann–Whitney test, Chi-square test, Kaplan–Meier curves including the log-rank test, and logistic regression model.ResultsWhen compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death.ConclusionsWe did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression.

Highlights

  • In Caucasians, incidences of malignant melanoma (MM) are increasing worldwide, with estimated continuous case increases for the decades

  • Disease relapse in Nodular melanoma (NM) patients was significantly associated with a positive sentinel lymph node biopsy (SLNB) (P = 0.0021), with higher tumor thickness (P = 0.0003), and higher Clark level (P = 0.013)

  • Positive SLNB status in NM patients was significantly associated with male sex (P = 0.0091), tumor thickness (P = 0.0055), and tumor location on the upper limbs (P = 0.022)

Read more

Summary

Introduction

In Caucasians, incidences of malignant melanoma (MM) are increasing worldwide, with estimated continuous case increases for the decades. The highest incidence is found in Queensland, Australia (about 70 cases/100.000/ year). In the USA, an increasing incidence from 14 to 22/100.000 person-years has been observed across all primary tumor thicknesses. The incidence of invasive MM increases in Europe mostly attributed to the increasing incidence of thin melanomas..

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call